About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

UNKNOWNNCT01224483

Multicenter Retrospective Analysis About the Clinical Characteristics of Korean Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients

Paroxysmal nocturnal hemoglobinuria (PNH) is a hematopoietic stem cell disorder in which unregulated activation of the complement system leads to significant ischemic morbidities with shortened lifesp...

Lead sponsor: Samsung Medical Center•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Samsung Medical Center

To evaluate the clinical characteristics in Korean PNH patients

Age

1 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Diagnosis confirmed by Ham's test or Flow cytometry Patients have any Flow cytometry data

Exclusion Criteria

•Patients have no Flow cytometry data

Related studies

COMPLETEDPhase 2

Mismatched Family Member Donor Transplantation for Children and Young Adults With High Risk Hematological Malignancies

NCT00566696 · Leukemia, Acute Lymphocytic (ALL), Leukemia, Myeloid, Acute(AML), and more

COMPLETEDPhase 2

Reduced Intensity Allogeneic PBSCT to Treat Hematologic Malignancies and Hematopoietic Failure States

NCT00997386 · Hematologic Neoplasms, Multiple Myeloma, and more

Approved For Marketing

The Paroxysmal Nocturnal Hemoglobinuria Early Access Treatment Protocol

NCT00438789 · Hemoglobinuria, Paroxysmal

The Molecular Biology of Paroxysmal Nocturnal Hemoglobinuria (PNH)

NCT00721864 · Hemoglobinuria, Paroxysmal

COMPLETEDPhase 3

Haploidentical Stem Cell Transplantation for Patients With Hematologic Malignancies

NCT00186823 · Leukemia, Acute Lymphocytic (ALL), Leukemia, Myeloid, Acute(AML), and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: October 20, 2010Terms

Trial snapshot

StatusUNKNOWN

Phase—

Enrollment350

Start dateAug 2010

Last updatedOct 20, 2010

Condition

Hemoglobinuria, Paroxysmal

Locations shown

Division of Hematology Oncology, Samsung Medical Center

Seoul

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 20, 2010Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions